Outcome of ventilator-associated pneumonia: Impact of antibiotic therapy and other factors

Australasian Medical Journal

Volumn 5, Issue 2, 2012, Pages 135-140

  Joseph, Noyal Mariya ^a   Sistla, Sujatha ^a   Dutta, Tarun Kumar ^a   Badhe, Ashok Shankar ^a   Rasitha, Desdemona ^a   Parija, Subhash Chandra ^a  

^a JAWAHARLAL INSTITUTE OF POSTGRADUATE MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Appropriate therapy; Outcome; Quantitative culture; Ventilator associated pneumonia

Indexed keywords

ANTIBIOTIC AGENT;

ADULT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; COHORT ANALYSIS; CONFIDENCE INTERVAL; CONTROLLED STUDY; FATALITY; FEMALE; HUMAN; INDIA; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATHOGENESIS; TERTIARY HEALTH CARE; TRACHEAL ASPIRATION PROCEDURE; VENTILATOR ASSOCIATED PNEUMONIA;

EID: 84862642977     PISSN: None     EISSN: 18361935     Source Type: Journal    
DOI: 10.4066/AMJ.2012.1004     Document Type: Article

References (16)

1. Davis KA. Ventilator-associated pneumonia: a review. J Intensive Care Med 2006;21:211-26.
2. Koenig SM, Truwit JD. Ventilator-associated pneumonia: diagnosis, treatment, and prevention. Clin Microbiol Rev 2006;19:637-57.
3. Alp E, Voss A. Ventilator associated pneumonia and infection control. Ann Clin Microbiol Antimicrob 2006;5:7.
4. Chastre J, Fagon JY. Ventilator-associated pneumonia. Am J Respir Crit Care Med 2002;165:867-903.
5. Rello J, Ollendorf DA, Oster G, Vera-Llonch M, Bellm L, Redman R, Kollef MH. Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 2002;122:2115-21.
6. Luna CM, Aruj P, Niederman MS, Garzon J, Violi D, Prignoni A, Ríos F, Baquero S, Gando S. Appropriateness and delay to initiate therapy in ventilator-associated pneumonia. Eur Respir J 2006;27:158-64.
7. Park DR. The microbiology of ventilator-associated pneumonia. Respir Care 2005;50:742-63.
8. Pugin J, Auckenthaler R, Mili N, Janssens JP, Lew PD, Suter PM. Diagnosis of ventilator-associated pneumonia by bacteriologic analysis of bronchoscopic and nonbronchoscopic blind bronchoalveolar lavage fluid. Am Rev Respir Dis 1991;143:1121-9.
9. Porzecanski I, Bowton DL. Diagnosis and treatment of ventilator-associated pneumonia. Chest 2006;130:597-604.
10. Wu CL, Yang DI, Wang NY, Kuo HT, Chen PZ. Quantitative culture of endotracheal aspirates in the diagnosis of ventilator-associated pneumonia in patients with treatment failure. Chest 2002;122:662-8.
11. Apostolopoulou E, Bakakos P, Katostaras T, Gregorakos L. Incidence and risk factors for ventilator-associated pneumonia in 4 multidisciplinary intensive care units in Athens, Greece. Respir Care 2003;48:681-8.
12. Balthazar AB, Von NA, De Capitani EM, Bottini PV, Terzi RG, Araujo S. Diagnostic investigation of ventilator-associated pneumonia using bronchoalveolar lavage: comparative study with a postmortem lung biopsy. Braz J Med Biol Res 2001;34:993-1001.
13. Combes A, Figliolini C, Trouillet JL, Kassis N, Wolff M, Gibert C, Chastre J. Incidence and outcome of polymicrobial ventilator-associated pneumonia. Chest 2002;121:1618-23.
14. Niederman MS, Craven DE. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416.
15. Rello J, Torres A, Ricart M, Valles J, Gonzalez J, Artigas A Rodriguez-Roisin R. Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes. Am J Respir Crit Care Med 1994;150:1545-9.
16. Depuydt PO, Vandijck DM, Bekaert MA, Decruyenaere JM, Blot SI, Vogelaers DP et al. Determinants and impact of multidrug antibiotic resistance in pathogens causing ventilator-associated-pneumonia. Crit Care 2008;12:R142.